190 related articles for article (PubMed ID: 9270000)
21. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
[TBL] [Abstract][Full Text] [Related]
22. High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas.
Kudo Y; Kitajima S; Sato S; Miyauchi M; Ogawa I; Takata T
Cancer Res; 2001 Oct; 61(19):7044-7. PubMed ID: 11585732
[TBL] [Abstract][Full Text] [Related]
23. The role of p27 in endometrial carcinoma.
Nycum LR; Smith LM; Farley JH; Kost ER; Method MW; Birrer MJ
Gynecol Oncol; 2001 May; 81(2):242-6. PubMed ID: 11330957
[TBL] [Abstract][Full Text] [Related]
24. Levels of expression of p27KIP1 protein in human prostate and prostate cancer: an immunohistochemical analysis.
Erdamar S; Yang G; Harper JW; Lu X; Kattan MW; Thompson TC; Wheeler TM
Mod Pathol; 1999 Aug; 12(8):751-5. PubMed ID: 10463475
[TBL] [Abstract][Full Text] [Related]
25. Impact of the expression of cyclin-dependent kinase inhibitor p27Kip1 and apoptosis in tumor cells on the overall survival of patients with non-early stage gastric carcinoma.
Ohtani M; Isozaki H; Fujii K; Nomura E; Niki M; Mabuchi H; Nishiguchi K; Toyoda M; Ishibashi T; Tanigawa N
Cancer; 1999 Apr; 85(8):1711-8. PubMed ID: 10223564
[TBL] [Abstract][Full Text] [Related]
26. Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer.
Kamai T; Takagi K; Asami H; Ito Y; Oshima H; Yoshida KI
Br J Cancer; 2001 May; 84(9):1242-51. PubMed ID: 11336477
[TBL] [Abstract][Full Text] [Related]
27. Skp2 is oncogenic and overexpressed in human cancers.
Gstaiger M; Jordan R; Lim M; Catzavelos C; Mestan J; Slingerland J; Krek W
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5043-8. PubMed ID: 11309491
[TBL] [Abstract][Full Text] [Related]
28. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
[TBL] [Abstract][Full Text] [Related]
29. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma.
Singh SP; Lipman J; Goldman H; Ellis FH; Aizenman L; Cangi MG; Signoretti S; Chiaur DS; Pagano M; Loda M
Cancer Res; 1998 Apr; 58(8):1730-5. PubMed ID: 9563491
[TBL] [Abstract][Full Text] [Related]
30. Low expression of p27(Kip1) is associated with tumor size and poor prognosis in patients with renal cell carcinoma.
Migita T; Oda Y; Naito S; Tsuneyoshi M
Cancer; 2002 Feb; 94(4):973-9. PubMed ID: 11920465
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of p27 expression in carcinoma of the oral cavity and oropharynx.
Venkatesan TK; Kuropkat C; Caldarelli DD; Panje WR; Hutchinson JC; Chen S; Coon JS
Laryngoscope; 1999 Aug; 109(8):1329-33. PubMed ID: 10443844
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of Jun activation domain-binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features.
Osoegawa A; Yoshino I; Kometani T; Yamaguchi M; Kameyama T; Yohena T; Maehara Y
Cancer; 2006 Jul; 107(1):154-61. PubMed ID: 16721818
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of the Rb expression in adenocarcinoma of the lung.
Sugio K; Tsukamoto S; Ushijima C; Yamazaki K; Kase S; Yamaguchi M; Ondo K; Yano T; Sugimachi K
Anticancer Res; 2001; 21(3B):1931-5. PubMed ID: 11497280
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of p16INK4A inactivation in non small-cell lung cancers.
Gazzeri S; Gouyer V; Vour'ch C; Brambilla C; Brambilla E
Oncogene; 1998 Jan; 16(4):497-504. PubMed ID: 9484839
[TBL] [Abstract][Full Text] [Related]
35. Reduced HIC-1 gene expression in non-small cell lung cancer and its clinical significance.
Hayashi M; Tokuchi Y; Hashimoto T; Hayashi S; Nishida K; Ishikawa Y; Nakagawa K; Tsuchiya S; Okumura S; Tsuchiya E
Anticancer Res; 2001; 21(1B):535-40. PubMed ID: 11299800
[TBL] [Abstract][Full Text] [Related]
36. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.
Guo Y; Sklar GN; Borkowski A; Kyprianou N
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2269-74. PubMed ID: 9815624
[TBL] [Abstract][Full Text] [Related]
37. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
[TBL] [Abstract][Full Text] [Related]
38. P16Ink4a tumor suppressor function in lung cancer cells involves cyclin-dependent kinase 2 inhibition by Cip/Kip protein redistribution.
Grimison B; Langan TA; Sclafani RA
Cell Growth Differ; 2000 Oct; 11(10):507-15. PubMed ID: 11063124
[TBL] [Abstract][Full Text] [Related]
39. Increased expression of SKP2 and phospho-MAPK/ERK1/2 and decreased expression of p27 during tumor progression of cervical neoplasms.
Chen TP; Chen CM; Chang HW; Wang JS; Chang WC; Hsu SI; Cho CL
Gynecol Oncol; 2007 Mar; 104(3):516-23. PubMed ID: 17079005
[TBL] [Abstract][Full Text] [Related]
40. Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis.
Masuda TA; Inoue H; Sonoda H; Mine S; Yoshikawa Y; Nakayama K; Nakayama K; Mori M
Cancer Res; 2002 Jul; 62(13):3819-25. PubMed ID: 12097295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
